-
Diagnosis of IDP in HIV-Infected Patients
What is required to make a secure diagnosis of chronic inflammatory demyelinating polyneuropathy in a patient with HIV?
Medscape HIV/AIDS, May 2004
-
ART Programs in Resource-Limited Settings
Is it feasible to initiate ART without access to immunologic or virologic monitoring?
Medscape HIV/AIDS, May 2004
-
Diagnosis of Syphilis Treatment Failure
What is the correct way to diagnose syphilis treatment failure both in HIV-positive and HIV-negative persons?
Medscape HIV/AIDS, April 2004
-
Management of HIV/HCV-Coinfected Child
There is a paucity of data on treatment of pediatric HIV/HCV coinfection. What is the suggested course of management for this patient?
Medscape HIV/AIDS, April 2004
-
Antiretroviral Therapy Switch for a Patient With Very Low CD4+ Cell Count and Hepatotoxicity
The doctor had a newly diagnosed patient with a CD4+ cell count of 11 cells/mcL who developed liver toxicity on efavirenz/zidovudine/lamivudine and fluconazole. What is the suggested management?
Medscape HIV/AIDS, April 2004
-
Abacavir Skin-Patch Testing
How reliable is abacavir skin-patch testing when deciding whether to restart treatment with abacavir in patients who discontinued that drug because of a suspected hypersensitivity reaction?
Medscape HIV/AIDS, March 2004
-
Focal Brain Lesions in HIV-Infected Patients
Following the widespread use of HAART, what changes have been noted regarding incidence and imaging of focal brain lesions among HIV-infected patients?
Medscape HIV/AIDS, March 2004
-
Building Enfuvirtide Regimens in Highly Experienced Patients
What options does one have when trying to construct an enfuvirtide-containing regimen in highly experienced patients?
Medscape HIV/AIDS, February 2004
-
What Regimen to Use After Lactic Acidosis?
One of the most serious adverse events associated with antiretroviral therapy is both life-threatening and necessitates caution when selecting subsequent regimens.
Medscape HIV/AIDS, February 2004
-
Optimal Treatment for Progressive Multifocal Leukoencephalopathy
HIV-infected patients with PML once faced a poor prognosis. What has changed, and what is the most appropriate management strategy for this neurologic condition?
Medscape HIV/AIDS, January 2004
-
Pegylated Interferon Therapy for Patient With HCV/HIV Coinfection?
Should this patient receive interferon-based treatment? Adrian M. Di Bisceglie, MD, FACP, discusses his approach.
Medscape Gastroenterology, January 2004
-
Change in Antiretroviral Therapy Regimen Due to Toxicities
What is a good NRTI substitution for a patient who is
both concerned about fat loss and has a history of
severe anemia?
Medscape HIV/AIDS, January 2004
-
HIV Disease Progression and Antiretroviral Therapy Initiation in Infants/Children
Antiretroviral treatment of adults and children with HIV
can vary significantly. Learn the key points regarding
treatment initiation in infants and children.
Medscape HIV/AIDS, January 2004
-
Postoperative Infection and Treatment Initiation in a Patient With AIDS
What are the guidelines for ART initiation in patients
with advanced immunodeficiency who experience
postoperative complications?
Medscape HIV/AIDS, January 2004
-
Counterfeit Antiretroviral Drugs
HIV clinicians in the developing world have yet another
challenge: screening out counterfeit antiretrovirals.
Medscape HIV/AIDS, December 2003
-
Diagnosis of Primary CNS Lymphoma
Primary CNS lymphoma is the most common CNS
neoplasm in HIV infection. Read this expert's advice on
how to confirm a diagnosis.
Medscape HIV/AIDS, December 2003
-
Tenofovir/Abacavir Drug Interaction?
What is causing the high failure rates in some studies testing combinations that contain both these antiretroviral drugs?
Medscape HIV/AIDS, November 2003
-
Therapeutic Drug Monitoring in HIV Infection
Therapeutic drug monitoring is becoming more widely
used in HIV management, but experts remain divided
regarding its routine clinical use.
Medscape HIV/AIDS, November 2003
-
Antiretroviral Therapy Regimens and Lipodystrophy
Patients starting antiretroviral therapy sometimes have
concerns about developing lipodystrophy. What advice
can HIV clinicians provide them?
Medscape HIV/AIDS, November 2003
-
Management of Enfuvirtide Injection-Site Reactions
Most patients who inject this HIV fusion inhibitor as part
of their HAART regimen experience mild-to-moderate
localized skin reactions.
Medscape HIV/AIDS, October 2003
